Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus

NCT06261021 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Discoid Lupus Erythematosus

Interventions

DRUG: Ruxolitinib 1.5% cream
PROCEDURE: Application without occlusion in Area 1
PROCEDURE: Application under occlusion at night in Area 2
PROCEDURE: Application under occlusion at night in Area 1
PROCEDURE: Application without occlusion in Area 2

Sponsor

Innovaderm Research Inc.